title: Control of breathing by raphe obscurus serotonergic neurons in mice.
abstract: We used optogenetics to determine the global respiratory effects produced by selectively stimulating raphe obscurus (RO) serotonergic neurons in anesthetized mice and to test whether these neurons detect changes in the partial pressure of CO(2), and hence function as central respiratory chemoreceptors. Channelrhodopsin-2 (ChR2) was selectively (∼97%) incorporated into ∼50% of RO serotonergic neurons by injecting AAV2 DIO ChR2-mCherry (adeno-associated viral vector double-floxed inverse open reading frame of ChR2-mCherry) into the RO of ePet-Cre mice. The transfected neurons heavily innervated lower brainstem and spinal cord regions involved in autonomic and somatic motor control plus breathing but eschewed sensory related regions. Pulsed laser photostimulation of ChR2-transfected serotonergic neurons increased respiratory frequency (fR) and diaphragmatic EMG (dEMG) amplitude in relation to the duration and frequency of the light pulses (half saturation, 1 ms; 5-10 Hz). dEMG amplitude and fR increased slowly (half saturation after 10-15 s) and relaxed monoexponentially (tau, 13-15 s). The breathing stimulation was reduced ∼55% by methysergide (broad spectrum serotonin antagonist) and potentiated (∼16%) at elevated levels of inspired CO(2) (8%). RO serotonergic neurons, identified by their entrainment to short light pulses (threshold, 0.1-1 ms) were silent (nine cells) or had a low and regular level of activity (2.1 ± 0.4 Hz; 11 cells) that was not synchronized with respiration. These and nine surrounding neurons with similar characteristics were unaffected by adding up to 10% CO(2) to the breathing mixture. In conclusion, RO serotonergic neurons activate breathing frequency and amplitude and potentiate the central respiratory chemoreflex but do not appear to have a central respiratory chemoreceptor function.
authors.affiliation: Department of Pharmacology, University of Virginia, Charlottesville, Virginia 22908, USA.
authors.forename: Seth D
authors.initials: SD
authors.lastname: Depuy
authors.forename: Roy
authors.initials: R
authors.lastname: Kanbar
authors.forename: Melissa B
authors.initials: MB
authors.lastname: Coates
authors.forename: Ruth L
authors.initials: RL
authors.lastname: Stornetta
authors.forename: Patrice G
authors.initials: PG
authors.lastname: Guyenet
mesh_terms: D000818:Animals; D017776:Autonomic Pathways / Q000502:physiology; D001703:Biophysics; D002232:Carbocyanines / Q000378:metabolism; D002254:Carbonates / Q000494:pharmacology; D000075402:Channelrhodopsins; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D003964:Diaphragm / Q000187:drug effects / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation / Q000379:methods; D004576:Electromyography / Q000379:methods; D005260:Female; D006935:Hypercapnia / Q000503:physiopathology; D008297:Male; D008784:Methysergide / Q000494:pharmacology; D051379:Mice; D009046:Motor Neurons / Q000502:physiology*; D010775:Photic Stimulation / Q000379:methods; D011903:Raphe Nuclei / Q000166:cytology*; D012119:Respiration / Q000187:drug effects / Q000235:genetics; D012701:Serotonin / Q000378:metabolism*; D012702:Serotonin Antagonists / Q000494:pharmacology; D018709:Statistics, Nonparametric; D014162:Transfection / Q000379:methods; D014365:Tryptophan Hydroxylase / Q000378:metabolism
chemical_list: D002232:Carbocyanines; D002254:Carbonates; D000075402:Channelrhodopsins; D012702:Serotonin Antagonists; C089187:cyanine dye 3; D012701:Serotonin; C005686:sodium carbonate; D014365:Tryptophan Hydroxylase; D002795:Choline O-Acetyltransferase; D008784:Methysergide